Social and psychological aspects of cervical screening

Expert Review of Obstetrics and Gynecology

Volumn 6, Issue 1, 2011, Pages 37-44

  Szarewski, Anne ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cervical smears; HPV; psychosocial; screening; sexually transmitted disease

Indexed keywords

WART VIRUS VACCINE;

ANXIETY; ATTITUDE TO HEALTH; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; FOLLOW UP; HEALTH PRACTITIONER; HUMAN; PAPILLOMAVIRUS INFECTION; PATIENT EDUCATION; PREVALENCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REVIEW; RURAL AREA; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SMOKING; SOCIAL ASPECT; URBAN AREA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; WART VIRUS;

EID: 78650491779     PISSN: 17474108     EISSN: None     Source Type: Journal    
DOI: 10.1586/eog.10.69     Document Type: Review

References (52)

1. Campion MJ, Brown JR, McCance DJ et al. Psychosexual trauma of an abnormal cervical smear. Br. J. Obstet. Gynaecol. 95(2), 175-181 (1988).
2. Kavanagh AM, Broom DH. Women's understanding of abnormal cervical smear test results: a qualitative interview study. Br. Med. J. 314(7091), 1388-1391 (1997).
3. Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am. J. Obstet. Gynecol. 165(3), 658-662 (1991).
4. McDonald TW, Neutens JJ, Fischer LM, Jessee D. Impact of cervical intraepithelial neoplasia diagnosis and treatment on self-esteem and body image. Gynecol. Oncol. 34(3), 345-349 (1989).
5. Posner T, Vessey M. Prevention of cervical cancer: the patient's view. King's Fund, London, UK (1988).
6. Gray NM, Sharp L, Cotton SC et al. Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br. J. Cancer 94(9), 1253-1262 (2006).
7. French DP, Maissi E, Marteau TM. Psychological costs of inadequate cervical smear test results. Br. J. Cancer 91(11), 1887-1892 (2004).
8. Armstrong N, Murphy E. Weaving meaning? An exploration of the interplay between lay and professional understandings of cervical cancer risk. Soc. Sci. Med. 67(7), 1074-1082 (2008).
9. Cuschieri KS, Horne AW, Szarewski A, Cubie HA. Public awareness of human papillomavirus. J. Med. Screen. 13(4), 201-207 (2006).
10. Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ. Res. 17(6), 706-714 (2002).
11. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among women attending a well woman clinic. Sex. Transm. Infect. 79(4), 320-322 (2003).
12. Waller J, McCaffery K, Wardle J. Beliefs about the risk factors for cervical cancer in a British population sample. Prev. Med. 38(6), 745-753 (2004).
13. Kahn JA, Slap GB, Bernstein DI et al. Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol. 26(2), 192-200 (2007).
14. Nielsen A, Munk C, Liaw KL, Kjaer SK. Awareness of human papillomavirus in 23 000 Danish men from the general male population. Eur. J. Cancer Prev. 18(3), 236-239 (2009).
15. Marlow LA, Wardle J, Grant N, Waller J. Human papillomavirus (HPV) information needs: a theoretical framework. J. Fam. Plann. Reprod. Health Care 35(1), 29-33 (2009).
16. McCaffery K, Irwig L. Australian women's needs and preferences for information about human papillomavirus in cervical screening. J. Med. Screen. 12(3), 134-141 (2005).
17. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. Br. Med. J. 328(7451), 1293 (2004).
18. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up. Br. J. Cancer 92(6), 990-994 (2005).
19. McCaffery KJ, Irwig L, Turner R et al. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. Br. Med. J. 340, b4491 (2010).
20. Dyson S, Pitts M, Lyons A, Mullins R. Providing high quality information about human papillomavirus for women after treatment for high-grade cervical dysplasia. Sex. Health 7(1), 49-54 (2010).
21. McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex. Transm. Infect. 82(2), 169-174 (2006).
22. Pitts MK, Dyson SJ, Rosenthal DA, Garland SM. Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia. Sex. Health 4(3), 177-180 (2007).
23. Goldsmith MR, Bankhead CR, Kehoe ST, Marsh G, Austoker J. Information and cervical screening: a qualitative study of women's awareness, understanding and information needs about HPV. J. Med. Screen. 14(1), 29-33 (2007).
24. Marlow LA, Waller J, Wardle J. Public awareness that HPV is a risk factor for cervical cancer. Br. J. Cancer 97(5), 691-694 (2007).
25. Daley EM, Perrin KM, McDermott RJ et al. The psychosocial burden of HPV: a mixed-method study of knowledge, attitudes and behaviors among HPV+ women. J. Health Psychol. 15(2), 279-290 (2010).
26. McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br. J. Cancer 88(1), 42-46 (2003).
27. Pirotta M, Ung L, Stein A et al. The psychosocial burden of human papillomavirus related disease and screening interventions. Sex. Transm. Infect. 85(7), 508-513 (2009).
28. McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 111(12), 1437-1443 (2004).
29. Waller J, Marlow LA, Wardle J. Anticipated shame and worry following an abnormal Pap test result: the impact of information about HPV. Prev. Med. 48(5), 415-419 (2009).
30. Forrest S, McCaffery K, Waller J et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J. Med. Screen. 11(2), 85-88 (2004).
31. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J. Med. Screen. 16(4), 193-198 (2009).
32. Marlow LA, Wardle J, Forster AS, Waller J. Ethnic differences in human papillomavirus awareness and vaccine acceptability. J. Epidemiol. Commun. Health 63(12), 1010-1015 (2009).
33. Anhang R, Wright TC Jr, Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer 100(2), 315-320 (2004).
34. Waller J, Marlow LA, Wardle J. The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sex. Transm. Infect. 83(2), 155-159 (2007).
35. Gilbert LK, Alexander L, Grosshans JF, Jolley L. Answering frequently asked questions about HPV. Sex. Transm. Dis. 30(3), 193-194 (2003).
36. Verhoeven V, Baay MF, Baay PE, Lardon F, Van Royen P, Vermorken JB. Everything you always wanted to know about HPV (but could not ask your doctor). Patient Educ. Couns. 81(1), 101-105 (2010).
37. Mast TC, Zhu X, Demuro-Mercon C, Cummings HW, Sings HL, Ferris DG. Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV. Curr. Med. Res. Opin. 25(11), 2609-2619 (2009).
38. Wang KL, Jeng CJ, Yang YC et al. The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions. J. Psychosom. Obstet. Gynaecol. 31(1), 16-23 (2010).
39. Verhoeven V, Baay M, Colliers A et al. The male factor in cervical carcinogenesis: a questionnaire study of men's awareness in primary care. Prev. Med. 43(5), 389-393 (2006).
40. Daley EM, Buhi ER, Baldwin J et al. Men's responses to HPV test results: development of a theory-based survey. Am. J. Health Behav. 33(6), 728-744 (2009).
41. Giordano L, Webster P, Anthony C et al. Improving the quality of communication in organised cervical cancer screening programmes. Patient Educ. Couns. 72(1), 130-136 (2008).
42. Szarewski A. Raising awareness of human papillomavirus and cervical cancer prevention: the need for clinical education. Future Virol. 4(5), 431-436 (2009).
43. Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF. Paediatricians' attitudes and practices towards HPV vaccination. Acta Paediatr. 97(11), 1550-1556 (2008).
44. Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer 101(5 Suppl.), 1214-1228 (2004).
45. Howe A, Owen-Smith V, Richardson J. The impact of a television soap opera on the NHS Cervical Screening Programme in the North West of England. J. Public Health Med. 24(4), 299-304 (2002).
46. Bowring J, Walker P. The 'Jade Goody effect': what now for cervical cancer prevention? J. Fam. Plann. Reprod. Health Care 36(2), 51-54 (2010).
47. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J. Med. Screen. 16(4), 199-204 (2009).
48. Bais AG, van Kemenade FJ, Berkhof J et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int. J. Cancer 120(7), 1505-1510 (2007).
49. Gok M, Heideman DA, van Kemenade FJ et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. Br. Med. J. 340, c1040 (2010).
50. Sanner K, Wikstrom I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br. J. Cancer 101(5), 871-874 (2009).
51. Szarewski A, Cadman L, Mallett S et al. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J. Med. Screen. 14(1), 34-42 (2007).
52. Waller J, McCaffery K, Forrest S et al. Acceptability of unsupervised HPV self-sampling using written instructions. J. Med. Screen. 13(4), 208-213 (2006)